(Reuters) – Johnson &amp; Johnson said on Monday John Reed will take the role of executive vice president of pharmaceuticals, research and development, effective April 3. 

Reed, 64, will replace William Hait, who was appointed the interim head of the unit in August 2022. 

Reed has previously served in executive positions for drugmakers Sanofi SA and Roche Holding AG. 

 (Reporting by Khushi Mandowara in Bengaluru; Editing by Shinjini Ganguli)

<ul class="dpsp-networks-btns-wrapper dpsp-networks-btns-share dpsp-networks-btns-content dpsp-column-3 dpsp-has-button-icon-animation" style="padding:0;margin:0;list-style-type:none">
<li class="dpsp-network-list-item dpsp-network-list-item-facebook" style="float:left"> <a rel="nofollow noopener" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.oann.com%2Fbusiness%2Fjohnson-johnson-names%2F&amp;t=Johnson%20%26amp%3B%20Johnson%20names%20ex-Sanofi%20executive%20as%20pharma%2C%20R%26amp%3BD%20vice%20president" class="dpsp-network-btn dpsp-facebook dpsp-first dpsp-has-label" target="_blank" aria-label="Share on Facebook" title="Share on Facebook" style="font-size:14px;padding:0rem;max-height:32px">	 Facebook</a></li> <li class="dpsp-network-list-item dpsp-network-list-item-twitter" style="float:left"> <a rel="nofollow noopener" href="https://twitter.com/intent/tweet?text=Johnson%20%26amp%3B%20Johnson%20names%20ex-Sanofi%20executive%20as%20pharma%2C%20R%26amp%3BD%20vice%20president&amp;url=https%3A%2F%2Fwww.oann.com%2Fbusiness%2Fjohnson-johnson-names%2F&amp;via=OANN" class="dpsp-network-btn dpsp-twitter dpsp-has-label" target="_blank" aria-label="Share on Twitter" title="Share on Twitter" style="font-size:14px;padding:0rem;max-height:32px">	 Twitter</a></li> <li class="dpsp-network-list-item dpsp-network-list-item-email" style="float:left"> <a rel="nofollow noopener" href="mailto:?subject=https%3A%2F%2Fwww.oann.com%2Fbusiness%2Fjohnson-johnson-names%2F&amp;body=Johnson%20%26amp%3B%20Johnson%20names%20ex-Sanofi%20executive%20as%20pharma%2C%20R%26amp%3BD%20vice%20president" class="dpsp-network-btn dpsp-email dpsp-last dpsp-has-label" target="_blank" aria-label="Send over email" title="Send over email" style="font-size:14px;padding:0rem;max-height:32px">	 Email</a></li>
</ul>

(Reuters) – Johnson & Johnson said on Monday John Reed will take the role of executive vice president of pharmaceuticals, research and development, effective April 3. &nbsp;Reed, 64, will replace William Hait, who was appointed the interim head of the unit in August 2022. &nbsp;Reed has previously served in executive positions for drugmakers Sanofi SA and Roche Holding AG. &nbsp;(Reporting by Khushi Mandowara in Bengaluru; Editing by Shinjini Ganguli) &nbsp;

Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president

Loading...